SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Activity
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

30 hedge funds and large institutions have $3.07M invested in Seelos Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
30
Holders Change
+6
Holders Change %
+25%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
6
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Sabby Management
Florida
$451K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$927K
3
VF
3
Virtu Financial
New York
$68K
4
WS
4
Wedbush Securities
California
$75K
5
CH
5
CVI Holdings
Delaware
$54K

Top Sellers

1
PSC
1
Piper Sandler & Co
Minnesota
$0
2
UIC
2
Uniplan Investment Counsel
Wisconsin
$604K
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
Squarepoint
4
Squarepoint
New York
$21K
5
PAM
5
Panagora Asset Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Group One Trading
26
Group One Trading
Illinois
$0 17 – –
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
HI
28
Hudock Inc
Pennsylvania
$0 1 – –
LFG
29
Larson Financial Group
Missouri
$0 2 – –
AG
30
Advisor Group
Arizona
$0 18 – –
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
$0 16 – –
UBS Group
32
UBS Group
Switzerland
$0 1 – –
Wells Fargo
33
Wells Fargo
California
$0 33 – –
IA
34
IFP Advisors
Florida
$0 16 +16 New
Northwestern Mutual Wealth Management
35
Northwestern Mutual Wealth Management
Wisconsin
$0 133 +133 New
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$0 456 +456 New
1
2